Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
暂无分享,去创建一个
H. Matsuda | H. Ichikawa | F. Nomura | Y. Sawa | N. Fukushima | K. Kagisaki | T. Ohata | K. Kadoba | S. Taketani | K. Suzuki | T. Masai
[1] P. Venge,et al. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. , 2008, Artificial organs.
[2] H. Matsuda,et al. Normothermia has beneficial effects in cardiopulmonary bypass attenuating inflammatory reactions. , 1995, ASAIO journal.
[3] W. Wagner,et al. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss. , 1994, The Annals of thoracic surgery.
[4] E. Fosse,et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.
[5] G. von Bernuth,et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.
[6] J. Weiler,et al. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.
[7] W. van Oeveren,et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[8] M. Elliott,et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.
[9] P. Venge,et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. , 1992, The Journal of thoracic and cardiovascular surgery.
[10] E. Fosse,et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.
[11] J. Pincemail,et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. , 1991, The Journal of thoracic and cardiovascular surgery.
[12] W. van Oeveren,et al. Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass , 1991 .
[13] D. Noonan,et al. C5a-mediated release of interleukin 6 by human monocytes. , 1990, Clinical immunology and immunopathology.
[14] W. W. Bailey,et al. Complement activation and lung permeability during cardiopulmonary bypass. , 1990, The Annals of thoracic surgery.
[15] E. Blackstone,et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. , 1986, The Annals of thoracic surgery.
[16] S Westaby,et al. Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.
[17] D. Stroncek,et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.
[18] R S Kronenberg,et al. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. , 1977, The New England journal of medicine.
[19] H. Maurer,et al. Impairment in platelet aggregation in congenital heart disease. , 1972, Blood.
[20] H. Matsuda,et al. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.
[21] B. Smith,et al. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.
[22] W. van Oeveren,et al. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.
[23] R. Larsson,et al. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.